Jasper Therapeutics Faces Class Action Lawsuit Over Alleged Misconduct
Rosen Law Firm has issued a reminder to investors who bought Jasper Therapeutics securities between November 30, 2023 and July 3, 2025. A class action lawsuit has been filed against the company, and investors may be entitled to compensation. The deadline for filing motions to be appointed as lead plaintiff is November 18, 2025.
The lawsuit alleges that Jasper Therapeutics made false or misleading statements and failed to disclose material information. Investors suffered damages when the truth was revealed. The lawsuit claims that Jasper Therapeutics lacked proper controls for third-party manufacturers, impacting the results of ongoing studies and the prospects of its products. To join the class action, investors can visit https://rosenlegal.com/submit-form/?case_id=45109 or contact Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected].
Investors who purchased Jasper Therapeutics securities during the specified period are encouraged to act before the November 18, 2025 deadline. The lawsuit seeks to recover damages suffered by investors due to the company's alleged misconduct.
